Cargando…
Lean Body Weight-Tailored Iodinated Contrast Injection in Obese Patient: Boer versus James Formula
PURPOSE: To prospectively compare the performance of James and Boer formula in contrast media (CM) administration, in terms of image quality and parenchymal enhancement in obese patients undergoing CT of the abdomen. MATERIALS AND METHODS: Fifty-five patients with a body mass index (BMI) greater tha...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110034/ https://www.ncbi.nlm.nih.gov/pubmed/30186869 http://dx.doi.org/10.1155/2018/8521893 |
_version_ | 1783350409143779328 |
---|---|
author | Caruso, Damiano De Santis, Domenico Rivosecchi, Flaminia Zerunian, Marta Panvini, Nicola Montesano, Marta Biondi, Tommaso Bellini, Davide Rengo, Marco Laghi, Andrea |
author_facet | Caruso, Damiano De Santis, Domenico Rivosecchi, Flaminia Zerunian, Marta Panvini, Nicola Montesano, Marta Biondi, Tommaso Bellini, Davide Rengo, Marco Laghi, Andrea |
author_sort | Caruso, Damiano |
collection | PubMed |
description | PURPOSE: To prospectively compare the performance of James and Boer formula in contrast media (CM) administration, in terms of image quality and parenchymal enhancement in obese patients undergoing CT of the abdomen. MATERIALS AND METHODS: Fifty-five patients with a body mass index (BMI) greater than 35 kg/m(2) were prospectively included in the study. All patients underwent 64-row CT examination and were randomly divided in two groups: 26 patients in Group A and 29 patients in Group B. The amount of injected CM was computed according to the patient's lean body weight (LBW), estimated using either Boer formula (Group A) or James formula (Group B). Patient's characteristics, CM volume, contrast-to-noise ratio (CNR) of liver, aorta and portal vein, and liver contrast enhancement index (CEI) were compared between the two groups. For subjective image analysis readers were asked to rate the enhancement of liver, kidneys, and pancreas based on a 5-point Likert scale. RESULTS: Liver CNR, aortic CNR, and portal vein CNR showed no significant difference between Group A and Group B (all P ≥ 0.177). Group A provided significantly higher CEI compared to Group B (P = 0.007). Group A and Group B returned comparable overall subjective enhancement values (3.54 and vs 3.20, all P ≥ 0.199). CONCLUSIONS: Boer formula should be the method of choice for LBW estimation in obese patients, leading to an accurate CM amount calculation and an optimal liver contrast enhancement in CT. |
format | Online Article Text |
id | pubmed-6110034 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-61100342018-09-05 Lean Body Weight-Tailored Iodinated Contrast Injection in Obese Patient: Boer versus James Formula Caruso, Damiano De Santis, Domenico Rivosecchi, Flaminia Zerunian, Marta Panvini, Nicola Montesano, Marta Biondi, Tommaso Bellini, Davide Rengo, Marco Laghi, Andrea Biomed Res Int Research Article PURPOSE: To prospectively compare the performance of James and Boer formula in contrast media (CM) administration, in terms of image quality and parenchymal enhancement in obese patients undergoing CT of the abdomen. MATERIALS AND METHODS: Fifty-five patients with a body mass index (BMI) greater than 35 kg/m(2) were prospectively included in the study. All patients underwent 64-row CT examination and were randomly divided in two groups: 26 patients in Group A and 29 patients in Group B. The amount of injected CM was computed according to the patient's lean body weight (LBW), estimated using either Boer formula (Group A) or James formula (Group B). Patient's characteristics, CM volume, contrast-to-noise ratio (CNR) of liver, aorta and portal vein, and liver contrast enhancement index (CEI) were compared between the two groups. For subjective image analysis readers were asked to rate the enhancement of liver, kidneys, and pancreas based on a 5-point Likert scale. RESULTS: Liver CNR, aortic CNR, and portal vein CNR showed no significant difference between Group A and Group B (all P ≥ 0.177). Group A provided significantly higher CEI compared to Group B (P = 0.007). Group A and Group B returned comparable overall subjective enhancement values (3.54 and vs 3.20, all P ≥ 0.199). CONCLUSIONS: Boer formula should be the method of choice for LBW estimation in obese patients, leading to an accurate CM amount calculation and an optimal liver contrast enhancement in CT. Hindawi 2018-08-13 /pmc/articles/PMC6110034/ /pubmed/30186869 http://dx.doi.org/10.1155/2018/8521893 Text en Copyright © 2018 Damiano Caruso et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Caruso, Damiano De Santis, Domenico Rivosecchi, Flaminia Zerunian, Marta Panvini, Nicola Montesano, Marta Biondi, Tommaso Bellini, Davide Rengo, Marco Laghi, Andrea Lean Body Weight-Tailored Iodinated Contrast Injection in Obese Patient: Boer versus James Formula |
title | Lean Body Weight-Tailored Iodinated Contrast Injection in Obese Patient: Boer versus James Formula |
title_full | Lean Body Weight-Tailored Iodinated Contrast Injection in Obese Patient: Boer versus James Formula |
title_fullStr | Lean Body Weight-Tailored Iodinated Contrast Injection in Obese Patient: Boer versus James Formula |
title_full_unstemmed | Lean Body Weight-Tailored Iodinated Contrast Injection in Obese Patient: Boer versus James Formula |
title_short | Lean Body Weight-Tailored Iodinated Contrast Injection in Obese Patient: Boer versus James Formula |
title_sort | lean body weight-tailored iodinated contrast injection in obese patient: boer versus james formula |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110034/ https://www.ncbi.nlm.nih.gov/pubmed/30186869 http://dx.doi.org/10.1155/2018/8521893 |
work_keys_str_mv | AT carusodamiano leanbodyweighttailorediodinatedcontrastinjectioninobesepatientboerversusjamesformula AT desantisdomenico leanbodyweighttailorediodinatedcontrastinjectioninobesepatientboerversusjamesformula AT rivosecchiflaminia leanbodyweighttailorediodinatedcontrastinjectioninobesepatientboerversusjamesformula AT zerunianmarta leanbodyweighttailorediodinatedcontrastinjectioninobesepatientboerversusjamesformula AT panvininicola leanbodyweighttailorediodinatedcontrastinjectioninobesepatientboerversusjamesformula AT montesanomarta leanbodyweighttailorediodinatedcontrastinjectioninobesepatientboerversusjamesformula AT bionditommaso leanbodyweighttailorediodinatedcontrastinjectioninobesepatientboerversusjamesformula AT bellinidavide leanbodyweighttailorediodinatedcontrastinjectioninobesepatientboerversusjamesformula AT rengomarco leanbodyweighttailorediodinatedcontrastinjectioninobesepatientboerversusjamesformula AT laghiandrea leanbodyweighttailorediodinatedcontrastinjectioninobesepatientboerversusjamesformula |